{
    "name": "nitroprusside sodium",
    "comment": "Rx",
    "other_names": [
        "Nipride RTU",
        "Nitropress",
        "Sodium Nitroprusside"
    ],
    "classes": [
        "Vasodilators"
    ],
    "source": "https://reference.medscape.com/drug/nipride-rtu-nitropress-nitroprusside-sodium-342312",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: not known if distributed into milk"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: not known if distributed into milk"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Not suitable for direct injection; requires dilution prior to infusion",
                "Hypotension may occur, leading to irreversible ischemic injury or death; requires appropriate monitoring equipment and experienced personnel",
                "Cyanide toxicity may occur because of accumulation of cyanide ion"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Compensatory HTN (eg, arteriovenous shunt or aortic coarctation); (for controlled hypotension): inadequate cerebral circulation",
                "Certain rare conditions, eg, congenital optic atrophy, tobacco amblyopia",
                "Treatment of acute CHF associated with reduced peripheral vascular resistance such as high-output heart failure that may be seen in endotoxic sepsis",
                "To produce hypotension during surgery in patients with known inadequate cerebral circulation, or in moribund patients (A.S.A. Class 5E) coming to emergency surgery"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Small transient excesses in the infusion rate of sodium nitroprusside can result in excessive hypotension, sometimes to levels so low as to compromise the perfusion of vital organs; nitroprusside-induced hypotension will be self-limited within 1-10 minutes after discontinuation of therapy; during these few minutes, it may be helpful to put the patient into a head-down (Trendelenburg) position to maximize venous return; if hypotension persists more than a few minutes after discontinuation of infusion therapy is not the cause, and the true cause must be sought",
                "Therapy can cause increases in intracranial pressure; in patients whose intracranial pressure is already elevated, sodium nitroprusside should be used only with extreme caution",
                "Use caution when administering nitroprusside to patients with hepatic insufficiency",
                "When sodium nitroprusside (or any other vasodilator) is used for controlled hypotension during anesthesia, the patient’s capacity to compensate for anemia and hypovolemia may be diminished; if possible, pre-existing anemia and hypovolemia should be corrected prior to administration of therapy",
                "Hypotensive anesthetic techniques may cause abnormalities of pulmonary ventilation/perfusion ratio; patients intolerant of these abnormalities may require a higher fraction of inspired oxygen",
                "Head trauma, increases ICP, hyponatremia, hypothyroidism, severe hepatic or renal impairment, elderly"
            ],
            "specific": [
                {
                    "type": "Cyanide toxicity",
                    "description": [
                        "Infusions at rates above 2 mcg/kg/min generate cyanide ion (CN¯) faster than the body can normally dispose of it",
                        "Methemoglobin normally present in the body can buffer a certain amount of CN¯, but the capacity is exhausted by the CN¯ produced from about 500 mcg/kg of sodium nitroprusside; this amount of sodium nitroprusside is administered in less than an hour when the drug is administered at 10 mcg/kg/min (the maximum recommended rate); thereafter, the toxic effects of CN¯ may be rapid, serious, and even lethal",
                        "Cyanide toxicity may manifest itself as venous hyperoxemia with bright red venous blood, as cells become unable to extract oxygen delivered to them; metabolic (lactic) acidosis; air hunger; confusion; and death",
                        "Cyanide toxicity due to causes other than nitroprusside has been associated with angina pectoris and myocardial infarction; ataxia, seizures, and stroke; and other diffuse ischemic damage",
                        "Hypertensive patients, and patients concomitantly receiving other antihypertensive medications, may be more sensitive to the effects of sodium nitroprusside than normal subjects",
                        "Check thiocyanate levels, monitor pulse oximeter",
                        "Thiocyanate clearance may decrease with renal failure"
                    ]
                },
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "The hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive drugs, including ganglionic blocking agents, negative inotropic agents, and inhaled anesthetics"
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "avanafil",
            "description": {
                "common": "nitroprusside sodium, avanafil.\nEither increases effects of the other by Mechanism: pharmacodynamic synergism. Contraindicated. Additive hypotensive effects."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "lofexidine",
            "description": {
                "common": "lofexidine, nitroprusside sodium.\nEither increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Avoid coadministration with other drugs that decrease pulse or blood pressure to mitigate risk of excessive bradycardia and hypotension."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "amlodipine",
            "description": {
                "common": "amlodipine increases effects of nitroprusside sodium by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "benazepril",
            "description": {
                "common": "nitroprusside sodium, benazepril.\nEither increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Additive hypotensive effects."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "bretylium",
            "description": {
                "common": "nitroprusside sodium, bretylium.\nEither decreases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Each drug may cause hypotension."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "bupivacaine implant",
            "description": {
                "common": "nitroprusside sodium, bupivacaine implant.\nEither increases toxicity of the other by Other (see comment). Use Caution/Monitor. \nComment: Local anesthetics may increase the risk of developing methemoglobinemia when concurrently exposed to drugs that also cause methemoglobinemia."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "clevidipine",
            "description": {
                "common": "clevidipine increases effects of nitroprusside sodium by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "clonidine",
            "description": {
                "common": "nitroprusside sodium, clonidine.\nEither increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Additive hypotensive effects."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dapsone topical",
            "description": {
                "common": "nitroprusside sodium increases toxicity of dapsone topical by altering metabolism. Modify Therapy/Monitor Closely. May induce methemoglobinemia."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dichlorphenamide",
            "description": {
                "common": "dichlorphenamide, nitroprusside sodium.\nEither increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Both drugs can cause metabolic acidosis."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "diltiazem",
            "description": {
                "common": "diltiazem increases effects of nitroprusside sodium by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "felodipine",
            "description": {
                "common": "felodipine increases effects of nitroprusside sodium by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "guanfacine",
            "description": {
                "common": "nitroprusside sodium, guanfacine.\nEither increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Additive hypotensive effects."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "isradipine",
            "description": {
                "common": "isradipine increases effects of nitroprusside sodium by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "maraviroc",
            "description": {
                "common": "maraviroc, nitroprusside sodium.\nEither increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of orthostatic hypotension."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nicardipine",
            "description": {
                "common": "nicardipine increases effects of nitroprusside sodium by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nifedipine",
            "description": {
                "common": "nifedipine increases effects of nitroprusside sodium by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nisoldipine",
            "description": {
                "common": "nisoldipine increases effects of nitroprusside sodium by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nitroglycerin rectal",
            "description": {
                "common": "nitroglycerin rectal, nitroprusside sodium.\nEither increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Observe for possible additive hypotensive effects during concomitant use. ."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sildenafil",
            "description": {
                "common": "nitroprusside sodium, sildenafil. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Additive hypotensive effects."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "tadalafil",
            "description": {
                "common": "nitroprusside sodium, tadalafil. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Additive hypotensive effects."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "tetracaine",
            "description": {
                "common": "tetracaine, nitroprusside sodium. Other (see comment). Use Caution/Monitor. \nComment: Monitor for signs of methemoglobinemia when methemoglobin-inducing drugs are coadministered."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "vardenafil",
            "description": {
                "common": "nitroprusside sodium, vardenafil. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Additive hypotensive effects."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "verapamil",
            "description": {
                "common": "verapamil increases effects of nitroprusside sodium by pharmacodynamic synergism. Use Caution/Monitor."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Bradyarrhythmia",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        },
        {
            "name": "palpitations",
            "percent": null
        },
        {
            "name": "tachyarrhythmia",
            "percent": null
        },
        {
            "name": "Apprehension",
            "percent": null
        },
        {
            "name": "restlessness",
            "percent": null
        },
        {
            "name": "confusion",
            "percent": null
        },
        {
            "name": "dizziness",
            "percent": null
        },
        {
            "name": "headache",
            "percent": null
        },
        {
            "name": "somnolence",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "sweating",
            "percent": null
        },
        {
            "name": "Thyroid suppression",
            "percent": null
        },
        {
            "name": "Injection site irritation",
            "percent": null
        },
        {
            "name": "Muscle twitch",
            "percent": null
        },
        {
            "name": "Oliguria",
            "percent": null
        },
        {
            "name": "renal azotemia",
            "percent": null
        },
        {
            "name": "Cardiac dysrhythmia",
            "percent": null
        },
        {
            "name": "hemorrhage",
            "percent": null
        },
        {
            "name": "decreased platelet aggregation",
            "percent": null
        },
        {
            "name": "excessive hypotensive response",
            "percent": null
        },
        {
            "name": "Raised intracranial pressure",
            "percent": null
        },
        {
            "name": "Metabolic acidosis",
            "percent": null
        },
        {
            "name": "Bowel obstruction",
            "percent": null
        },
        {
            "name": "Methemoglobinemia",
            "percent": null
        },
        {
            "name": "Cyanide poisoning",
            "percent": null
        },
        {
            "name": "Thiocyanate toxicity",
            "percent": null
        }
    ]
}